<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02724696</url>
  </required_header>
  <id_info>
    <org_study_id>IFCT-1104 RYTHMIC</org_study_id>
    <nct_id>NCT02724696</nct_id>
  </id_info>
  <brief_title>French National Observatory of Patients With Thymic Epithelial Tumor</brief_title>
  <acronym>RYTHMIC</acronym>
  <official_title>French National Observatory of Patients With Thymic Epithelial Tumor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intergroupe Francophone de Cancerologie Thoracique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intergroupe Francophone de Cancerologie Thoracique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the
      objective of territorial coverage by regional expert centers and systematic discussion of
      patients management at national tumor board.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in
      2012 by the French National Cancer Institute. The objectives of the network are management of
      clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is
      based on initial histopathological diagnosis.

      RYTHMIC is a comprehensive tool for research:

        -  to improve the management of patients

        -  to monitor dedicated actions

        -  to screen patients for future translational and clinical trials
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>histological type</measure>
    <time_frame>5 years</time_frame>
    <description>histological type according to the WHO classification 2004/2015</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Masaoka-Koga stage</measure>
    <time_frame>5 years</time_frame>
    <description>Masaoka-Koga stage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ITMIG/IASLC 2014/2015 stage</measure>
    <time_frame>5 years</time_frame>
    <description>ITMIG/IASLC 2014/2015 stage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questions raised at the national expert multidisciplinary tumor board</measure>
    <time_frame>5 years</time_frame>
    <description>Diagnosis/Imaging, Surgery, Chemotherapy, Radiotherapy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1750</enrollment>
  <condition>Thymic Epithelial Tumor</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Thymic Epithelial Tumors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with Thymic Epithelial Tumors

        Exclusion Criteria:

          -  histology other than Thymic Epithelial Tumors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin BESSE, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Villejuif - Gustave Roussy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Franck Morin</last_name>
    <email>contact@ifct.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lyon- Hôpital Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas GIRARD, Pr</last_name>
      <email>contact@ifct.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Villejuif - Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin BESSE, Dr</last_name>
      <email>contact@ifct.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Chalabreysse L, Thomas De Montpreville V, De Muret A, Hofman V, Lantuejoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Marx A, Besse B, Molina TJ. [Rythmic-pathology: the French national pathology network for thymic epithelial tumours]. Ann Pathol. 2014 Feb;34(1):87-91. doi: 10.1016/j.annpat.2014.01.010. Epub 2014 Feb 21. French.</citation>
    <PMID>24630641</PMID>
  </reference>
  <reference>
    <citation>Hadoux J, Girard N, Besse B. [Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France]. Bull Cancer. 2012 Nov;99(11):1045-55. doi: 10.1684/bdc.2012.1659. Review. French.</citation>
    <PMID>23131309</PMID>
  </reference>
  <reference>
    <citation>Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes. Pathol Res Pract. 2015 Dec;211(12):996-1002. doi: 10.1016/j.prp.2015.10.005. Epub 2015 Oct 19.</citation>
    <PMID>26534878</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2016</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
    <mesh_term>Thymus Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

